These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20447554)

  • 1. Investigation of the pharmacokinetics of 3'-deoxy-3'-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer.
    Menda Y; Ponto LL; Dornfeld KJ; Tewson TJ; Watkins GL; Gupta AK; Anderson C; McGuire S; Schultz MK; Sunderland JJ; Graham MM; Buatti JM
    Nucl Med Biol; 2010 May; 37(4):433-8. PubMed ID: 20447554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of 3'-deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) in head and neck cancer patients before and early after initiation of chemoradiation therapy.
    Menda Y; Boles Ponto LL; Dornfeld KJ; Tewson TJ; Watkins GL; Schultz MK; Sunderland JJ; Graham MM; Buatti JM
    J Nucl Med; 2009 Jul; 50(7):1028-35. PubMed ID: 19525472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-deoxy-3'-[¹⁸F]fluorothymidine PET quantification of bone marrow response to radiation dose.
    McGuire SM; Menda Y; Boles Ponto LL; Gross B; Buatti J; Bayouth JE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):888-93. PubMed ID: 21300484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of 3'-deoxy-3'-[18F]fluorothymidine standardized uptake values in head and neck cancer over time.
    Boles Ponto LL; Menda Y; Dornfeld K; Tewson TJ; Watkins GL; Sunderland J; Graham MM; Buatti J
    Cancer Biother Radiopharm; 2010 Jun; 25(3):361-3. PubMed ID: 20578842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using [(18)F]Fluorothymidine Imaged With Positron Emission Tomography to Quantify and Reduce Hematologic Toxicity Due to Chemoradiation Therapy for Pelvic Cancer Patients.
    McGuire SM; Bhatia SK; Sun W; Jacobson GM; Menda Y; Ponto LL; Smith BJ; Gross BA; Bayouth JE; Sunderland JJ; Graham MM; Buatti JM
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):228-39. PubMed ID: 27319286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in (18)F-fluorothymidine and (18)F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy.
    Hoshikawa H; Mori T; Kishino T; Yamamoto Y; Inamoto R; Akiyama K; Mori N; Nishiyama Y
    Ann Nucl Med; 2013 May; 27(4):363-70. PubMed ID: 23378102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
    Agool A; Slart RH; Thorp KK; Glaudemans AW; Cobben DC; Been LB; Burlage FR; Elsinga PH; Dierckx RA; Vellenga E; Holter JL
    Nucl Med Commun; 2011 Jan; 32(1):17-22. PubMed ID: 21166089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
    J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome.
    Hoeben BA; Troost EG; Span PN; van Herpen CM; Bussink J; Oyen WJ; Kaanders JH
    J Nucl Med; 2013 Apr; 54(4):532-40. PubMed ID: 23345303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.
    Muzi M; Vesselle H; Grierson JR; Mankoff DA; Schmidt RA; Peterson L; Wells JM; Krohn KA
    J Nucl Med; 2005 Feb; 46(2):274-82. PubMed ID: 15695787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of 3'-deoxy-3'-18F-fluorothymidine PET for predicting early response to chemoradiotherapy in head and neck cancer.
    Kishino T; Hoshikawa H; Nishiyama Y; Yamamoto Y; Mori N
    J Nucl Med; 2012 Oct; 53(10):1521-7. PubMed ID: 22872738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine.
    Buck AK; Bommer M; Juweid ME; Glatting G; Stilgenbauer S; Mottaghy FM; Schulz M; Kull T; Bunjes D; Möller P; Döhner H; Reske SN
    J Nucl Med; 2008 Nov; 49(11):1756-62. PubMed ID: 18927328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
    Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
    J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models.
    Choi SJ; Kim SY; Kim SJ; Lee JS; Lee SJ; Park SA; Lee SJ; Yun SC; Im KC; Oh SJ; Kim SW; Kim JS; Ryu JS; Moon DH
    Nucl Med Biol; 2009 Oct; 36(7):711-9. PubMed ID: 19720283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.
    Agool A; Schot BW; Jager PL; Vellenga E
    J Nucl Med; 2006 Oct; 47(10):1592-8. PubMed ID: 17015893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLT PET Radiomics for Response Prediction to Chemoradiation Therapy in Head and Neck Squamous Cell Cancer.
    Ulrich EJ; Menda Y; Boles Ponto LL; Anderson CM; Smith BJ; Sunderland JJ; Graham MM; Buatti JM; Beichel RR
    Tomography; 2019 Mar; 5(1):161-169. PubMed ID: 30854454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Inubushi M; Saga T; Koizumi M; Takagi R; Hasegawa A; Koto M; Wakatuki M; Morikawa T; Yoshikawa K; Tanimoto K; Fukumura T; Yamada S; Kamada T
    Ann Nucl Med; 2013 Jan; 27(1):1-10. PubMed ID: 22914968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
    Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
    J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.